Literature DB >> 1531028

Effects of dimethyl sulfoxide on catalysis in Escherichia coli F1-ATPase.

M K al-Shawi1, A E Senior.   

Abstract

(1) Dimethyl sulfoxide (DMSO) markedly inhibited the Vmax of multisite ATPase activity in Escherichia coli F1-ATPase at concentrations greater than 30% (v/v). Vmax/KM was reduced by 2 orders of magnitude in 40% (v/v) DMSO at pH 7.5, primarily due to reduction of Vmax. The inhibition was rapidly reversed on dilution into aqueous buffer. (2) KdATP at the first, high-affinity catalytic site was increased 1500-fold from 2.3 x 10(-10) to 3.4 x 10(-7) M in 40% DMSO at pH 7.5, whereas KdADP was increased 3.2-fold from 8.8 to 28 microM. This suggests that the high-affinity catalytic site presents a hydrophobic environment for ATP binding in native enzyme, that there is a significant difference between the conformation for ADP binding as opposed to ATP binding, and that the ADP-binding conformation is more hydrophilic. (3) Rate constants for hydrolysis and resynthesis of bound ATP in unisite catalysis were slowed approximately 10-fold by 40% DMSO; however, the equilibrium between bound Pi/bound ATP was little changed. The reduction in catalysis rates may well be related to the large increase in KdATP (less constrained site). (4) Significant Pi binding to E. coli F1 could not be detected either in 40% DMSO or in aqueous buffer using a centrifuge column procedure. (5) We infer, on the basis of the measured constants KaATP, K2 (hydrolysis/resynthesis of ATP), k+3 (Pi release), and KdADP and from estimates of k-3 (Pi binding) that delta G for ATP hydrolysis in 40% DMSO-containing pH 7.5 buffer is between -9.2 and -16.8 kJ/mol.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1531028     DOI: 10.1021/bi00118a034

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  13 in total

Review 1.  Catalytic sites of Escherichia coli F1-ATPase.

Authors:  A E Senior
Journal:  J Bioenerg Biomembr       Date:  1992-10       Impact factor: 2.945

Review 2.  Medicinal chemistry of ATP synthase: a potential drug target of dietary polyphenols and amphibian antimicrobial peptides.

Authors:  Zulfiqar Ahmad; Thomas F Laughlin
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

Review 3.  ATP synthase and the actions of inhibitors utilized to study its roles in human health, disease, and other scientific areas.

Authors:  Sangjin Hong; Peter L Pedersen
Journal:  Microbiol Mol Biol Rev       Date:  2008-12       Impact factor: 11.056

Review 4.  Two ATPases.

Authors:  Alan E Senior
Journal:  J Biol Chem       Date:  2012-07-20       Impact factor: 5.157

Review 5.  ATP synthase: a molecular therapeutic drug target for antimicrobial and antitumor peptides.

Authors:  Zulfiqar Ahmad; Florence Okafor; Sofiya Azim; Thomas F Laughlin
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

6.  Properties of bound inorganic phosphate on bovine mitochondrial F1F0-ATP synthase.

Authors:  S Beharry; P D Bragg
Journal:  J Bioenerg Biomembr       Date:  2001-02       Impact factor: 2.945

7.  Phosphate exchange and ATP synthesis by DMSO-pretreated purified bovine mitochondrial ATP synthase.

Authors:  S Beharry; P D Bragg
Journal:  Biochem J       Date:  2001-01-15       Impact factor: 3.857

8.  Unisite hydrolysis of [gamma 32 P]ATP by soluble mitochondrial F1-ATPase and its release by excess ADP and ATP. Effect of trifluoperazine.

Authors:  J J García; A Gómez-Puyou; M T de Gómez-Puyou
Journal:  J Bioenerg Biomembr       Date:  1997-02       Impact factor: 2.945

9.  Role of {alpha}-subunit VISIT-DG sequence residues Ser-347 and Gly-351 in the catalytic sites of Escherichia coli ATP synthase.

Authors:  Wenzong Li; Laura E Brudecki; Alan E Senior; Zulfiqar Ahmad
Journal:  J Biol Chem       Date:  2009-02-23       Impact factor: 5.157

10.  Novel features of the rotary catalytic mechanism revealed in the structure of yeast F1 ATPase.

Authors:  Venkataraman Kabaleeswaran; Neeti Puri; John E Walker; Andrew G W Leslie; David M Mueller
Journal:  EMBO J       Date:  2006-11-02       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.